COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence

•Incidence of COVID 19 was not increased in patients with inflammatory rheumatisms.•Continuation of anti-rheumatic drugs was not associated with an increased risk of COVID-19.•In inflammatory rheumatisms treatment adherence was reduced because of fear of contagion. To explore how patients with chron...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2021-01, Vol.88 (1), p.105095-105095, Article 105095
Hauptverfasser:	Costantino, Félicie, Bahier, Léa, Tarancón, Luis Coronel, Leboime, Ariane, Vidal, François, Bessalah, Lamouri, Breban, Maxime, D’Agostino, Maria-Antonietta
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - therapeutic use Comorbidity COVID-19 COVID-19 - epidemiology Female France - epidemiology Glucocorticoids - therapeutic use Human health and pathology Humans Life Sciences Male Middle Aged Non-steroidal anti-inflammatory drugs Original Pandemics Prognosis Psoriatic arthritis Retrospective Studies Rheumatic Diseases - drug therapy Rheumatic Diseases - epidemiology Rheumatoid arthritis Rhumatology and musculoskeletal system Risk Factors SARS-CoV-2 Spondyloarthritis Treatment Adherence and Compliance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!